Loading...

Home
ETF
BBIO

BBIO

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

BBIO News

DKSH Partners with BridgeBio for ATTR-CM Treatment Access

Jun 11 2026Yahoo Finance

Wall Street's Latest Ratings Overview

Jun 03 2026CNBC

BridgeBio Pharma's BBP-418 Receives FDA Priority Review

May 27 2026seekingalpha

BridgeBio's BBP-418 Receives FDA Priority Review for LGMD2I/R9

May 27 2026Newsfilter

BridgeBio Pharma Shares Drop After Downgrade by Raymond James

May 26 2026seekingalpha

Cardiovascular Disease Costs Set to Skyrocket, Urgent Need for AI Solutions

May 12 2026PRnewswire

Cardiovascular Disease Costs Surge, AI Technology Becomes Key

May 12 2026Newsfilter

BridgeBio's Encaleret Shows Promising Phase 3 Results for ADH1

May 12 2026Newsfilter

BridgeBio Reports New Data on Acoramidis Efficacy

May 11 2026NASDAQ.COM

Acoramidis Shows Significant Benefits in ATTR-CM Study

May 11 2026Newsfilter

BridgeBio Pharma Reports Strong Q1 2026 Earnings and $500M Buyback

May 08 2026seekingalpha

BridgeBio Pharma Q1 Earnings Report Analysis

May 07 2026seekingalpha

Brazil Approves Acoramidis for Cardiomyopathy Treatment

May 06 2026Newsfilter

BridgeBio to Present ADH1 Study Data at European Congress of Endocrinology

May 05 2026Newsfilter

BridgeBio to Present New Data at Heart Failure Conference

May 04 2026Newsfilter

Pfizer Settles Patent Disputes with Generic Manufacturers

Apr 28 2026stocktwits